Latest news

Bioservo signs distribution agreement with Tecno Italia

Loxam has placed orders for 18 Ironhand[®] systems (regulatory information)

World’s first soft robotic muscle strengthening system. Developed in collaboration with leading Fortune 500 companies

Menu

07 Feb, 2020

Loxam has placed their first Ironhand orders

Loxam has placed orders for their first 82 Ironhand® systems at an order value of MSEK 5,6. The systems will be available for rental in 15 cities across France, fulfilling the demand for increased safety of workers across the country.

Loxam and Bioservo signed an exclusive agreement in December 2019, an agreement that allows Loxam to offer Ironhand for rental all over France. Now the first orders of 82 Ironhand systems, including consumables and accessories, have been placed with a planned delivery schedule in batches during the spring.

“Rental has proved to be an excellent way to try out our Ironhand system and validate that it actually is efficient and brings value to the work situations at hand”, says Petter Bäckgren, CEO Bioservo. He continues: “We are excited about the fact that Ironhand has been so well received and appreciated by the workers that have used the system. There are many testimonials about reduced muscle stress and fatigue”.


For more information, please contact
Petter Bäckgren, CEO of Bioservo Technologies AB
Phone: +46 (0)8 21 17 10

petter.backgren@bioservo.com

Mikael Wester, Marketing Director of Bioservo Technologies AB
Phone: +46 (0)8 21 17 10

mikael.wester@bioservo.com

About Bioservo Technologies
Bioservo Technologies AB (publ) is a technology and development company that combines medical science with modern robotics. The company holds a leading global position within soft exoskeleton technology – wearable non-invasive devices – for people in need of extra power to optimize the body’s endurance and performance, or for people with reduced muscle strength.

Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.

FNCA Sweden AB, +46(0)8 528 00399, info@fnca.se is the Company’s Certified Adviser on Nasdaq First North Growth Market.

For more information, please visit www.bioservo.com